Imax’s Q4 should mark return to growth, says Roth MKM

Roth MKM keeps a Buy rating and $27 price target on Imax, noting that the most challenging box office quarter for the company have now passed. Q4 should mark a return to growth and kick off what should be a strong, 2-or-more year content cycle, with added benefits of a stronger release slate and a larger number of “Filmed For IMAX” movies, the analyst tells investors in a research note.